Aniruddha Amrite PhD MBA, founder and principal consultant at Clin PharmDev Solutions, has over 17 years of experience in pharmaceutical development with diverse treatment modalities including small molecules, monoclonal antibodies, oligonucleotides (RNA/siRNA), and antibody-drug conjugates.
He has expertise in all phases of drug development and has lead successful clinical development programs leading to a registration and approval of 5 commercially available drugs in different therapeutic indications including oncology, rare-diseases, and CV-metabolism.
He has held leadership positions in several Pharmaceutical and Biotechnology companies including Pyxis Oncology, Novo Nordisk (Dicerna), GSK (TESARO), Theravance Biopharma and IQVIA (Quintiles)